Summary
In a large kindred in which the gene for central core disease is segregating, we have demonstrated linkage between the disorder and a marker on chromosome 19q. Marker D19S9 (p1J2) was linked to central core disease with a lod score of 6.4 at θ = 0.03 (support interval 0.01–0.14) thus localizing the gene for this disorder in or very close to 19q12–q13.2.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andresen E, Jensen P (1977) Close linkage established between the HAL locus for halothane sensitivity and the PHI (phosphohexose isomerase) locus in pigs of the Danish Landrace breed. Nord Vet Med 29:502–504
Bethlem J, Gool J van, Hulsman WC, Meijer AEFH (1966) Familial non-progressive myopathy with muscle cramps after exercise. Brain 89:569–588
Byrne E, Blumbergs PC, Hallpike JF (1982) Central core disease. Study of a family with five affected generations. J Neurol Sci 53:77–83
Denborough MA, Dennett X, Anderson R McD (1973) Central core disease and malignant hyperpyrexia. Br Med J 1:272–273
Dubowitz V, Brooke MH (1973) Muscle biopsy: a modern approach. In: Walton JN (ed) Major problems in neurology, chap 2. Saunders, London Philadelphia, pp 20–32
Dubowitz V, Pearse AGE (1960) Oxidative enzymes and phosphorylase in central core disease of muscle. Lancet II:23–24
Frank JP, Harati Y, Butler IJ, Nelson TE, Scott CI (1980) Central core disease and malignant hyperthermia syndrome. Ann Neurol 7:11–17
Gahne B, Juneja RK (1985) Prediction of the halothane (Hal) genotypes of pigs by deducing Hal, Phi, PO2, Pgd haplotypes of parents and offspring: results from a large-scale practice in Swedish breeds. Anim Blood Groups Biochem Genet 16:265–283
Isaacs H, Heffron JJA, Badenhorst M (1975) Central core disease: a correlated genetic, physiochemical, ultramicroscopic and biochemical study. J Neurol Neurosurg Psychiatry 38:1177–1186
Kidd KK, Bowcock AM, Schmidtke J, Track RK, Rucciutti F, Hutchings G, Bale A, Pearson P, Willard HF (1989) Report of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms. (10th International Workshop on Human Gene Mapping) Cytogenet Cell Genet 51:622–947
Le Beau MM, Ryan D, Pericak-Vance MA (1989) Report of the committee on the genetic constitution of chromosomes 18 and 19. (10th International Workshop on Human Gene Mapping) Cytogenet Cell Genet 51:338–357
MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, Britt BA, Worton RG (1990) Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 343:559–561
McCarthy TV, Healy JMS, Heffron JA, Lehane M, Deufel T, Lehmann-Horn F, Farrall M, Johnson K (1990) Localisation of the malignant hyperthermia susceptibility locus to 19q12–13. 2. Nature 343:562–564
Mulley JC, Gedeon AK, Thorn KA, Bates LJ, Sutherland GR (1987) Linkage and genetic counselling for the fragile X using DNA probes 52A, F9, DX13 and ST14. Am J Med Genet 27:435–448
Nakamura Y, Lathrop M, O'Connell P, Leppert M, Lalouel J-M, White R (1988) A primary map of ten DNA markers and two serological markers for human chromosome 19. Genomics 3:67–71
Ott J (1976) A computer program for linkage analysis of general human pedigrees. Am J Hum Genet 28:528–529
Shuaib A, Paasuke LG, Brownell KW (1987) Central core disease. Clinical features in 13 patients. Medicine 66:389–396
Shy GM, Magee KR (1956) A new congenital non-progressive myopathy. Brain 79:610–621
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haan, E.A., Freemantle, C.J., McCure, J.A. et al. Assignment of the gene for central core disease to chromosome 19. Hum Genet 86, 187–190 (1990). https://doi.org/10.1007/BF00197703
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00197703